NEWS AT A GLANCE
SAP buys intelligence business
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
IBM and Google unveiled an initiative to help university students learn to program and research over the Internet, in what is called “cloud computing.” The $30 million-plus investment will build and allow students to access clusters of powerful, parallel computer servers located remotely. (The New York Times, free registration required) Both companies are invested heavily in cloud computing, and the initiative will help train their potential workforce, but that’s not all. “They’d like to influence the future of online business before Microsoft extends its influence,” said IDC analyst Frank Gens. (The Wall Street Journal)
MSNBC buys ‘citizen’ journalist site
MSNBC Interactive News, the joint Microsoft-NBC venture, bought Newsvine, a social news site, for an undisclosed amount. It is the first acquisition in MSNBC’s 11-year history. Netvine, started two years ago, features news stories and commentary, along with other media, written or posted by users. It has six employees and about a million viewers a month. (The Seattle Times) Several mainstream news outlets are trying to incorporate more user-generated content. “We set out to create an environment where big and little media could live in one place and make each other better,” said Netvine founder Mike Davidson. (The New York Times, free registration required)
What’s in a name? $500,000
The drug-branding industry has grown alongside the booming pharmaceutical business, and a good name is worth a lot. Consultants get paid between $200,000 and $500,000 to come up with a name for a new drug that won’t lead to medical mix-ups, sounds good, and has not already been claimed—30,000 drug names are trademarked in the U.S., nearly 150,000 in Europe. But there is method to branders’ madness. A high-tech drug? Use an X. “There are certain letters that express power and control, like Z, M, or P,” says drug-marketing professor William Trombetta at St. Joseph’s University in Philadelphia. “A lot of it is more art than science.” (The Indianapolis Star in USA Today)
